Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioHarvest Sciences ( (BHST) ) has shared an announcement.
On August 13, 2025, BioHarvest Sciences announced that its board of directors has adopted an amended insider trading policy. The new policy adjusts the trading window to open after the close of trading on the second full trading day following the public release of quarterly or year-end results and closes fifteen days before the due date of these results. This change aims to provide a more reasonable trading period, potentially impacting how stakeholders engage with the company’s stock.
The most recent analyst rating on (BHST) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences’ strong revenue growth and strategic initiatives are promising, but financial instability and valuation concerns weigh heavily. Technical indicators are positive but suggest caution due to overbought conditions.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. operates in the biotechnology industry, focusing on developing and commercializing proprietary biofarming technology to produce active plant ingredients for use in nutraceuticals, cosmetics, and potentially pharmaceuticals.
Average Trading Volume: 11,621
Technical Sentiment Signal: Buy
Current Market Cap: $159.7M
For an in-depth examination of BHST stock, go to TipRanks’ Overview page.